- CEO
- Pattabhi Rama Rao Posani
- Full Time Employees
- 114
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Address
- Gowra Fountain Head, D.No-1-90 Hyderabad TS India 500081
- IPO Date
- Apr 5, 1994
- Business
- Bhaskar Agrochemicals Limited Bhaskar Agrochemicals Limited engages in the manufacture and supply of agrochemical formulations and related products to domestic and international customers. The company produces a wide range of formulations, including emulsion concentrates (EC), soluble concentrates (SC), wettable powders (WP), water dispersible granules (WDG), coated granules (CG), dusting powders (DP), soluble powders, suspension concentrates, soluble liquids, slurry, oil paste, dry seed dressing, wettable granules, soluble granules, granules, neem extract concentrates, botanical extracts; plant growth regulators and promoters; organic bio-fertilizers; and miscellaneous agrochemicals such as insecticides (e.g., imidacloprid 17.8% SL, 70% WG, lambda cyhalothrin 5% EC, fipronil 5% SC, cartap hydrochloride 4% GR), fungicides (e.g., streptomycin sulphate + tetracycline hydrochloride 9:1 SP), herbicides, weedicides, micronutrients, and fertilizers. It operates primarily in the fertilizers and agricultural chemicals industry, targeting farmers and agricultural sectors with products compliant to international quality standards.
Founded in 1988 and headquartered in Hyderabad, Telangana, India, with a manufacturing facility in Choutuppal Mandal, Nalgonda District (now Telangana), the company supplies to markets in India and overseas, supported by a production capacity focused on pesticides, fertilizers, and plant protection solutions. Its registered office is at D.No-1-90/C, Office Unit-608, 1T06, 6th Floor, Madhapur, Hyderabad, 500081, India.
In recent developments, Bhaskar Agrochemicals Limited scheduled a board meeting on November 14, 2025, to consider financial results and other key matters, reflecting ongoing strategic oversight amid stock activity on the BSE (ticker: 524534). The company maintains active operations with its latest annual general meeting held on September 30, 2024, and balance sheet filed for the period ending March 31, 2024, while reporting total income of Rs. 29.55 crores in Q2 FY24, indicating sustained financial engagement in the sector.[instafinancials content] No major acquisitions, partnerships, or new product launches were publicly reported in the last 1-2 years, with focus remaining on core formulation production and market supply.